Clinical Trials on Pulmonary Disease, Chronic Obstructive (COPD) in France

Total 4717 results

University Hospital, Caen

Completed

Breathing-swallowing Interaction in Chronic Obstructive Pulmonary Disease Patients - Impact of Non Invasive Ventilation

Chronic Obstructive Pulmonary Disease (COPD) | Decompensated COPD With (Acute) Exacerbation

France
University Hospital, Brest

Recruiting

Influence of Temperature on Transcutaneous Blood Gas Diffusion: CAPNOS Project (CAPNOS)

Healthy Volunteers, Pathologies for Which paCO2 Monitoring is Crucial, Particularly in the Context of Chronic Obstructive Pulmonary Disease (COPD)

France
Assistance Publique Hopitaux De Marseille

Unknown

Pulmonary Vascular Impairment in Chronic Obstructive Pulmonary Disease (COPD) Assessed by MRI (PulmoVasc)

Chronic Obstructive Pulmonary Disease (COPD)

France
University Hospital, Bordeaux

Completed

Description of the Ability to Learn How to Handle Inhaler Devices in COPD (INTUITIVE)

Chronic Obstructive Pulmonary Disease (COPD)

France
CHU de Reims

Completed

Regeneration of Bronchial Epithelium During Chronic Obstructive Pulmonary Disease (EPITHREGENCOPD)

COPD

France
Centre Hospitalier des Pays de Morlaix
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Completed

Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients

Chronic Obstructive Pulmonary Disease | COPD

France
University Hospital, Grenoble

Completed

Prevalence, Associated Factors Points and Implementation of Care Procedures of Chronic Obstructive Pulmonary Disease Exacerbation in Healthcare Institution (OPEDEXA)

COPD Exacerbation

France
Centre Hospitalier Universitaire de Besancon

Completed

Detection and Characterization of COPD in Dairy Farmers (BALISTIC)

Chronic Obstructive Pulmonary Disease (COPD) | Environmental Exposure

France
Assistance Publique Hopitaux De Marseille

Completed

EFFECT OF SMOKING ON MUCUS HYPERSECRETION MECHANISMS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

France
Clinact
Assistance Publique - Hôpitaux de Paris; Fondation du Souffle

Recruiting

Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease | COPD Exacerbation

France
University Hospital, Clermont-Ferrand

Unknown

Non Invasive Evaluation of Muscle Hypoxia in COPD Patient (EVANIMUS) (EVANIMUS)

Hypoxemia | COPD (Chronic Obstructive Pulmonary Disease)

France
Centre Hospitalier Universitaire, Amiens

Completed

Biomarkers of Chronic Obstructive Pulmonary Disease (BIOBPCO)

Asthma | COPD | Asthma-COPD Overlap Syndrome

France
Nuvaira, Inc.

Completed

Evaluation of the IPS System for TLD Therapy in Patients With COPD (IPS-II)

Chronic Obstructive Pulmonary Disease (COPD)

France, Austria
University Hospital, Montpellier
5 Santé

Completed

Antioxidants and Pulmonary Rehabilitation in COPD Patients (AREB-1)

Chronic Obstructive Pulmonary Disease | COPD

France
Novartis

Completed

Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, France
University Hospital, Montpellier

Terminated

Determinants of Lower Limb Muscle Atrophy Induced During an Hospitalization for Exacerbation of COPD (AMI-EX-BPCO)

Muscle Atrophy | Chronic Obstructive Pulmonary Disease (COPD) | Exacerbation Copd

France
University Hospital, Brest

Completed

Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease (SAVE)

Smoking | Chronic Obstructive Pulmonary Disease | COPD Exacerbation

France
AstraZeneca

Completed

The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)

Chronic Obstructive Pulmonary Disease, COPD

France, Poland, South Africa, Spain, United States, Canada, United Kingdom
Laval University
Institut universitaire de cardiologie et de pneumologie de Québec, University... and other collaborators

Recruiting

Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases (6MST)

Interstitial Lung Disease | COPD Chronic Obstructive Pulmonary Disease

Canada, France
Sunovion

Completed

A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
Novartis

Completed

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States, Spain, Turkey, France, Netherlands, Germany
Groupe Hospitalier du Havre

Recruiting

Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation? (PREDICT)

Pulmonary Rehabilitation | COPD | COPD Exacerbation

France
Chiesi SAS
Kappa Santé

Recruiting

Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study (TriNEXT)

COPD

France
Novartis

Completed

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, Belgium, Spain, Turkey, Italy, Canada, Australia
Air Liquide Santé International
ITEC Services; Lincoln Medical and Mental Health Center

Completed

The COPD Patient Management European Trial (COMET) (COMET)

Chronic Obstructive Pulmonary Disease (COPD)

France, Spain, Germany, Italy
Centre Hospitalier Intercommunal de Toulon La Seyne...
Université de Toulon

Completed

Neuromuscular Fatigue in Chronic Obstructive Pulonary Disease (NEUROTIGUE)

Chronic Obstructive Pulmonary Disease (COPD)

France
Nuvaira, Inc.

Completed

Targeted Lung Denervation for Patients With Moderate to Severe COPD (AIRFLOW)

Chronic Obstructive Pulmonary Disease (COPD)

France, Belgium, Netherlands, Austria, Germany, United Kingdom
Biosency
Rennes University Hospital; Slb Pharma; Air de Bretagne; Centre Hospitalier Bretagne... and other collaborators

Recruiting

Study of Physiological Signals During and After COPD Exacerbations (DACRE)

COPD | COPD Exacerbation

France
University Hospital, Bordeaux

Recruiting

Evaluation by Electrical Impedancemetry of the Variation in Lung Volumes Under Non-invasive Ventilation (NIV) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (Eval 3V-BPCO)

COPD

France
AstraZeneca

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)

Chronic Obstructive Pulmonary Disease | COPD

Austria, France, Hungary, Italy, Poland, Portugal, Russian Federation, South Africa, Spain, Canada, United Kingdom, Australia, Netherlands, Switzerland
University Hospital, Angers

Unknown

High Flow Oxygen Therapy in Patients Suffering From Chronic Obstructive Pulmonary Disease Exacerbation: Effects and Mechanisms of Action (Oh BPCO)

COPD Exacerbation

France
University Hospital, Rouen

Completed

Change in Breathing Pattern on Non-invasive Ventilation of COPD Patients Under Home Mechanical Ventilation

Copd | COPD Exacerbation

France
AstraZeneca
Parexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaborators

Completed

Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (AERISTO)

Chronic Obstructive Pulmonary Disease COPD

United States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
AstraZeneca

Completed

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
AstraZeneca

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, United Kingdom, United States, Australia, Austria, Brazil, Hungary, New Zealand, Romania, Russian Federation
Novartis

Completed

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control

Chronic Obstructive Pulmonary Disease (COPD)

Russian Federation, Germany, Denmark, Italy, Canada, Czech Republic, Hungary, India, Slovakia, France, Colombia, Finland, Taiwan, Iceland, Peru
AstraZeneca

Completed

OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)

Chronic Obstructive Pulmonary Disease | COPD

United States, France, Poland, South Africa, Canada, Germany
Edmond Pharma

Unknown

The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD) (RESTORE)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium, Bulgaria, Czech Republic, Denmark, France, Italy, Poland, Romania, Slovakia, United Kingdom
AstraZeneca

Completed

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127) (EOS)

Chronic Obstructive Pulmonary Disease (COPD)

Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Spain, United Kingdom
AstraZeneca

Completed

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. (ASCENT COPD)

Chronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPD

United States, Canada
Novartis Pharmaceuticals

Completed

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

Chronic Obstructive Pulmonary Disease, COPD

Poland, United States
Aeris Therapeutics

Completed

AeriSeal System for Lung Volume Reduction

Lung Diseases | Emphysema | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease (COPD)

Israel, Austria, France, Germany
Hospital de Clinicas de Porto Alegre

Completed

Activity of Inspiratory Muscles With the Use of Positive Pressure in Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease (INTRUST2)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Colombia, Spain, Canada, Slovakia, India, Netherlands, Czech Republic, Hungary
AstraZeneca

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, United States, Canada, India, Italy, Poland, South Africa
University Hospital, Grenoble

Completed

Brain During Effort : Effects of Hypoxia With Respiratory Patients (NEUROX)

Healthy Volunteers | Chronic Obstructive Pulmonary Disease (COPD) | Sleep Apnea Obstructive (OSA)

France
University Hospital, Montpellier

Terminated

Sevoflurane in Chronic Obstructive Pulmonary Disease Exacerbation (SEVOCOPD)

COPD Exacerbation | Invasive Mechanical Ventilation

France
AstraZeneca

Completed

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Chronic Obstructive Pulmonary Disease, COPD

Sweden, France, Germany, Hungary, Poland, Canada, Australia, Slovakia, Spain
AstraZeneca

Completed

Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Austria, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, United Kingdom
Novartis Pharmaceuticals

Completed

A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Colombia, Egypt, Hungary, France, Guatemala, Panama, Slovakia, Slovenia

Clinical Trials on Pulmonary Disease, Chronic Obstructive (COPD) in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations